Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2011 | 04-2010 | 04-2009 | 04-2008 | 04-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,448 | -10,507 | -33,219 | -6,721 | -3,331 |
| Depreciation Amortization | 311 | 111 | 21 | 103 | 152 |
| Accounts receivable | 39 | -671 | -134 | 111 | 13 |
| Other Working Capital | 1,074 | 235 | 73 | -243 | 355 |
| Other Operating Activity | 621 | 2,246 | 29,202 | 4,475 | 1,673 |
| Operating Cash Flow | $-8,403 | $-8,587 | $-4,058 | $-2,276 | $-1,138 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -241 | -236 | -100 | -84 | N/A |
| Purchase Sale Intangibles | -223 | -306 | -268 | -18 | -19 |
| Other Investing Activity | -223 | -306 | -268 | -18 | -19 |
| Investing Cash Flow | $-464 | $-542 | $-367 | $-102 | $-19 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 6,905 | N/A |
| Debt Issued | 4,390 | 97 | 90 | 232 | 1,244 |
| Debt Repayment | N/A | -84 | N/A | N/A | N/A |
| Common Stock Issued | 4,901 | 10,030 | 2,098 | 221 | N/A |
| Common Stock Repurchased | N/A | -2,837 | N/A | N/A | N/A |
| Other Financing Activity | -105 | 0 | -88 | -116 | -71 |
| Financing Cash Flow | $9,186 | $7,206 | $2,100 | $7,243 | $1,173 |
| Beginning Cash Position | 633 | 2,556 | 4,881 | 16 | 0 |
| End Cash Position | 952 | 633 | 2,556 | 4,881 | 16 |
| Net Cash Flow | $319 | $-1,923 | $-2,325 | $4,864 | $16 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,403 | -8,587 | -4,058 | -2,276 | -1,138 |
| Capital Expenditure | -241 | -236 | -100 | -84 | N/A |
| Free Cash Flow | -8,644 | -8,823 | -4,157 | -2,360 | -1,138 |